Neurology Rare Disease Center

Denton, Texas 76208

4 studies enrolling now · 10 studies all time

What they study most

Becker Muscular Dystrophy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), DMD, Duchenne, Duchenne Muscular Dystrophy, Exon 44, Generalized Myasthenia Gravis, Myotonic Dystrophy Type 1 (DM1), Neuromuscular Diseases, SMA, Spinal Muscular Atrophy

Studies at this site

• A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis — Recruiting now
• Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 — Recruiting now
• A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) — Recruiting now
• Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy — Enrolling by invitation
• Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) — Running, not enrolling
• Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping — Running, not enrolling
• CureDuchenne Link®: A Resource for Research — Completed
• Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy — Completed
• A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy — Running, not enrolling
• A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND) — Running, not enrolling